(Q46035400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

Nosratola D Vaziri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Mohammad Kamgar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Frank Zaldivar

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Madeleine V Pahl

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

336-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Oxidative stress in uremia: nature, mechanisms, and potential consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Oxidative stress and inflammation in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Antioxidant therapy in uremia: evidence-based medicine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Relationship between red blood cell lipid peroxidation, plasma hemoglobin, and red blood cell osmotic resistance before and after vitamin E supplementation in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Protective effect of vitamin C on 8-hydroxy-2'-deoxyguanosine level in peripheral blood lymphocytes of chronic hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Homocysteine and lipid peroxidation in haemodialysis: role of folinic acid and vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effect of High-Dose Thiamine and Pyridoxine on Advanced Glycation End Products and Other Oxidative Stress Markers in Hemodialysis Patients: A Randomized Placebo-Controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Expression of catalase and glutathione peroxidase in renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Inflammation in ESRD: causes and potential consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Pro-oxidative effect of alpha-tocopherol in the oxidation of LDL isolated from co-antioxidant-depleted non-diabetic hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

Oxidative stress in haemodialysis: immediate changes caused by passage of blood through the dialyser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-9684%2815%2930881-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0027-9684(15)30881-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19397224%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference